PMID: 11314115Apr 21, 2001Paper

Sugar replacers and the FDA noncariogenicity claim

Journal of Dental Hygiene : JDH
K McNutt

Abstract

In 1996, the U.S. Food and Drug Administration (FDA) approved the use of a "health claim" based on the association between sugar replacers and the nonpromotion of dental caries. Small packages of products containing such sweeteners may state "Does not promote tooth decay" or "May reduce the risk of tooth decay." Larger packages must include additional information, such as "Frequent eating of foods high in sugars and starches as between-meal snacks can promote tooth decay." FDA criteria state that these products must not only be "sugar-free," but they must also contain a noncariogenic sugar replacer and not lower plaque pH below 5.7 either during consumption or up to 30 minutes after consumption when tested by in vivo pH telemetry. Many people might reduce their caries risk by using sugar-free products, and the FDA claim can help consumers identity such products. Dental hygienists are ideal sources of consumer information about sugar replacers, and can help clients distinguish between the new FDA claim and advertising claims that are not regulated by FDA. The purpose of this article is to provide dental hygienists with information on sugar replacers that will help clients make appropriate nutrition choices.

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.